Retroviral Reverse Transcriptases (Molecular Biology Intelligence Unit)

(12)
Retroviral Reverse Transcriptases (Molecular Biology Intelligence Unit) image
ISBN-10:

3540608907

ISBN-13:

9783540608905

Author(s): Simon Litvak
Released: Jul 30, 1996
Publisher: Springer
Format: Hardcover, 206 pages

Description:

Reverse transcriptase is an enzyme which is crucial in the replication of retroviruses (pathogen agents which may cause tumors, leukemias and AIDS). The structure and function of this enzyme is described with special emphasis on the human immunodeficiency virus type 1 (HIV-1) reverse transcriptase since a multidisciplinary gigantic effort has been devoted to this enzyme because of its link with AIDS. The presence of reverse transcriptase in other animal, plant, yeast and bacterial systems is mentioned. The last part of the book is devoted to the search of specific inhibitors of the retroviral reverse transcriptase, some of which are already used in clinics against pathologies produced by these agents.

Best prices to buy, sell, or rent ISBN 9783540608905




Related Books

Frequently Asked Questions about Retroviral Reverse Transcriptases (Molecular Biology Intelligence Unit)

You can buy the Retroviral Reverse Transcriptases (Molecular Biology Intelligence Unit) book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $98.20 on Amazon and is available from 1 sellers at the moment.

If you’re interested in selling back the Retroviral Reverse Transcriptases (Molecular Biology Intelligence Unit) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Retroviral Reverse Transcriptases (Molecular Biology Intelligence Unit) book, the best buyback offer comes from and is $ for the book in good condition.

Not enough insights yet.

Not enough insights yet.